Legal support of investment projects in healthcare
The investment process is always associated with risks. It is important for an investor to find the appropriate form of investment, mitigate risks and protect investments. The main thing is to achieve the investment goal.
Legal Alliance, with over 25 years of experience, has a unique industry expertise and is a recognized leader in supporting major pharmaceutical companies, medical facilities, and implementing international healthcare projects in Ukraine.
We offer comprehensive legal support for investment projects in the healthcare sector, both for investors and for local governments and state-owned (municipal) enterprises. In particular, interaction between business and the government can be carried out through the public-private partnership (PPP) projects, as well as in other forms, that will help to mitigate existing risks and get most of the benefits of investments.
PPP is a flexible and, most importantly, an effective tool for both investors and state-owned (municipal) organizations and enterprises, which has a number of advantages:
SERVICES
For investors:
For local governments and state-owned (municipal) enterprises:
EXPERIENCE (some of recently completed projects)
Support for entering the Ukrainian market of an international company that provides services in the healthcare sector and related services, with the aim of investing in the healthcare sector in three technically and medically complex areas. Legal Alliance proposed options for the implementation of investment projects and completed one of the PPP options – a concession, with the following approach: (1) The investor contributes his managerial experience in the project, allocates funds for the repair of the relevant municipal premises and their equipment with modern medical equipment, gradually returns his investment and, after some time of implementation of his business plan, transfers the modernized facility of the concession to the society; (2) The community receives high-quality medical services, which are mainly financed under agreements between the relevant hospital and the National Health Service of Ukraine (NHSU), a renewed medical infrastructure and new jobs.
Legal support also included the opening of the investor's subsidiary in Ukraine, preparation of all legal documents, support of operating activities. The project continues and is actively developing in all planned directions.
Legal support of a European pharmaceutical company entering the Ukrainian market with dermatological products. The team of Legal Alliance carried out a search for a Ukrainian startup, which received the rights of exclusive distribution of the company's products, legal and organizational support for the transaction, as well as subsequent support for the project's operational activities. The project continues to develop.
Helping an investor modernize a district hospital, being reformed into the municipal non-profit enterprise and was in dire financial condition. Working out of recommendations for improving all key processes of the hospital, in particular, regarding: optimization of the organizational structure and increasing labour efficiency; introduction of a list of paid medical and non-medical services to generate income; cooperation with insurance companies and providing an appropriate level of service; consolidation of property and financial resources by creating a municipal economic association by several enterprises; optimizing production functions and involving third-party suppliers or charities for specific functions; modernization of the remuneration system; investment raising for modernization and development, provision of the latest medical services and others.
Support to a Canadian pharmaceutical manufacturer, one of the leaders of the North American pharmaceutical industry, entering the Ukrainian market in 2012 - establishment of a representative office, development of a business concept in Ukraine, distribution agreements, complete internal documentation and building a comprehensive compliance system, assistance in registering pharmaceutical products in Ukraine. Subsequently, the client decided to sell his business in Ukraine and close its own operations in the region. Legal Alliance provided a comprehensive due diligence support and, subsequently, supported the liquidation of the representative office.
Launch of the Swiss Pharmaceutical Company's representative office in Ukraine in 2016 - establishing a representative office, drafting all necessary internal documents and contracts, and development of all internal business processes. In 2021, we restructured the Ukrainian representative office, reduced the number of staff, and provided the necessary organizational and legal support to comply with labor laws.
LA advised an international pharmaceutical company Roche on investments in Ukraine's pharmaceutical sector by establishing local medicine production facilities and participating in a PPP.
LA Law Firm has improved its standing in the "Market Leaders. Ranking of Law Firms — 2025" an annual assessment by the editorial board of Yuridychna Gazeta.
Medical Procurement of Ukraine and the international pharmaceutical company Roche have entered into an investment agreement to localize the manufacturing of oncology medicines in Ukraine.
Lawyers of LA Law Firm continue to be recognized as leading individuals by Client's Choice. TOP 100 Best Lawyers of Ukraine – 2025: leaders who shape the future
LA Law Firm has improved its standing in the "Market Leaders. Ranking of Law Firms — 2025" an annual assessment by the editorial board of Yuridychna Gazeta.
Medical Procurement of Ukraine and the international pharmaceutical company Roche have entered into an investment agreement to localize the manufacturing of oncology medicines in Ukraine.
The national ranking features three partners and a counsel across four practice categories. Managing partner Dmytro Aleshko named among the TOP 100 legal practitioners in Ukraine and leaders in Medical Law / Pharmaceuticals.
Leadership lessons for lawyers often focus on how to face up to tough times and take difficult decisions, but few managing partners will have had to square up to the challenges faced by Dmytro Aleshko since February 2022.